Hi Carissa,
The themes should guide the content submitted for programming. As long as the content proposed fits one of the themes below, it will be considered.
Track 2: Novel Strategies to Advance Biotherapeutic Development
Advances in therapeutic development for targeted delivery, platform technology, high-content bioanalysis, and data science.
Theme 1: Development Strategy for Novel Targeted Therapeutic Delivery
Keywords: Targeted Delivery, Bioanalysis, Pharmacokinetics
As the field of targeted drug delivery advances with new modalities such as lipid nanoparticles, cell therapies, and gene therapeutics, science is also gaining ground in the design of protein therapeutics tailored to deliver to specific tissues (examples: eye, tumor, or brain) and methods for bioanalysis. Discuss how pharmacokinetics, pharmacodynamics, and immunogenicity bioanalysis and data for tissue-targeted therapeutics can inform and advance therapeutic development.
Theme 2: Advances in Analytical and Bioanalytical Platform Technology
Keywords: Instrumentation Platforms, Flow Cytometry, Multiplexing, Imaging, Data Science
The field of analytical platform technology is racing to keep pace with the emergence of new modalities such as oligonucleotides and cell and gene therapies, as well as the increasing need for more informative analytical evaluation of traditional therapeutics such as monoclonal antibodies and antibody drug conjugates. Discuss high-resolution instrumentation techniques, multiplexing, flow cytometry, imaging platforms, and other technological advancements. Submissions are also welcome related to the associated developments in data science that add increased information to biodistribution, pharmacokinetics, immunogenicity, and pharmacodynamics analyses.
Theme 3: High Content Bioanalysis
Keywords: MAPPS, In-Silico Prediction, Immunogenicity Prediction, Artificial Intelligence, Machine Learning, personalized medicine, Omics
High Content Bioanalysis in genomics, proteomics, metabolomics, and lipidomics, along with technologies to identify and measure biomarkers at the single cell level, combined with advances in data sciences (artificial intelligence) are exponentially evolving. Discuss case studies and platforms for high content bioanalysis for personalized medicine, novel -omic approaches, immunogenicity prediction, immunogenicity risk assessments, and digital biomarkers. Submissions are also welcome that explore evolving data science and artificial intelligence methodologies for analysis of large data sets.
------------------------------
Karen Quadrini, PhD
Director, Biomarkers and Precision Medicine
Passage Bio
Philadelphia, PA
[email protected]Disclaimer: Opinions expressed are solely my own and do not express the views or opinions of my employer.
------------------------------
Original Message:
Sent: 09-27-2023 09:33
From: Carissa Jones
Subject: Deadline Extended to Oct 3rd 5PM ET: 2024 NBC Call for Programming
Hi Karen,
Are there any guidelines on content for the biomarker sessions? Meaning, is there a framework for the type of content you'd like to see?
Thanks,
Carissa
------------------------------
Carissa Jones
President
Mercodia Inc.
Winston Salem NC
[email protected]
Disclaimer: Opinions expressed are solely my own and do not express the views or opinions of my employer.
Original Message:
Sent: 09-26-2023 16:15
From: Karen Quadrini
Subject: Deadline Extended to Oct 3rd 5PM ET: 2024 NBC Call for Programming
The deadline for proposal submissions for symposia, rapid fires and hot topics for NBC 2024 has been extended to Tuesday, October 3rd, 5 PM ET. If you are thinking of submitting a proposal but have not had the opportunity yet, there is now another week to do so!
Review the Track 2 biomarker and bioanalysis-focused themes and additional details related to submissions here 2024 NBC Call for Programming
------------------------------
Karen Quadrini, PhD
Director, Biomarkers and Precision Medicine
Passage Bio
Philadelphia, PA
[email protected]
Disclaimer: Opinions expressed are solely my own and do not express the views or opinions of my employer.
------------------------------